Microbicide Innovation Program (MIP II) (R21/R33)
The summary for the Microbicide Innovation Program (MIP II) (R21/R33) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Microbicide Innovation Program (MIP II) (R21/R33): -The Microbicide Innovation Program (MIP II) solicits research in the field of topical microbicides using the NIH Phased Innovation Award (R21/R33). -The R21/R33 phased innovation award will support the innovative exploratory and developmental research initiated through a milestone-driven process under the R21 phase to establish the feasibility of new microbicides, microbicide strategies and support technologies, and through the R33 phase provide the support required to translate the innovation discoveries into the preclinical/ clinical development pipeline. -Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Awards will support milestone-driven exploratory/feasibility proof of concept studies (2 year R21 phase), with possible rapid transition to expanded development (3 year R33 phase).
| Federal Grant Title: | Microbicide Innovation Program (MIP II) (R21/R33) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AI-06-042 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.24293.855 |
| CFDA Descriptions: | Mental Health Research Grants 93.855 Allergy, Immunology and Transplantation Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Dec 21, 2006 |
| Posted Date: | Sep 12, 2006 |
| Creation Date: | Sep 12, 2006 |
| Archive Date: | Jan 20, 2007 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.856 -- Microbiology and Infectious Diseases Research |
- Applicants Eligible for this Grant
- Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Private institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) State governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Applicants may submit more than one application, provided each application is scientifically distinct. Clinical trials (defined as Phase I, II or III) or first-time-in human studies will not be supported under this announcement. Clinical research, that uses clinical specimens or uses collection of behavioral or social data and/or phase 0 studies as defined by the FDA http://www.fda.gov/cder/guidance/7086fnl.htm, may be supported under this announcement. Applicants are strongly urged to discuss any proposal containing clinical elements with Program prior to submission. When clinical studies or trials are a component of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. AN UPDATED NIAID policy was published in the NIH Guide on July 8, 2002 and is available at: http://grants.nih.gov/grants/guide/notice-files/NOT-AI-02-032.html. The full policy, including terms and conditions of award, is available at: http://www.niaid.nih.gov/ncn/pdf/clinterm.pdf.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster